![]() | This article has multiple issues. Please help
improve it or discuss these issues on the
talk page. (
Learn how and when to remove these template messages)
|
TREAT-NMD | |
---|---|
Translational Research in Europe - Assessment and Treatment of Neuromuscular diseases | |
Keywords | Neuromuscular diseases, clinical research |
Project type | Network of Excellence |
Funding agency | European Commission |
Reference | FP6-036825 |
Objective | Improving trial-readiness worldwide, advancing patient diagnosis and care and accelerating pre-clinical research |
Project coordinator | Institute of Genetic Medicine, Newcastle University |
Participants | Universities, pharmaceutical companies, patient organisations |
Website |
www |
TREAT-NMD (treat NeuroMuscular Disease) is a global academic network that focuses on advancing research in neuromuscular disorders. [1] It was established in 2007 with its coordination centre at the Newcastle University. [2] As of 2018, the network comprises over a hundred research centres and patient organisations from 54 countries [3] as well as independent academics and patient representatives. [4] The network's aim is to provide infrastructure to accelerating research through supporting collaboration between its members. [5] Its main goals include improving trial-readiness worldwide, advancing patient diagnosis and care and accelerating pre-clinical research. [6] [7]
Through patient registries, TREAT-NMD provides genotype– phenotype correlation between genetic mutations and neuromuscular disease burden. [8]
![]() | This article has multiple issues. Please help
improve it or discuss these issues on the
talk page. (
Learn how and when to remove these template messages)
|
TREAT-NMD | |
---|---|
Translational Research in Europe - Assessment and Treatment of Neuromuscular diseases | |
Keywords | Neuromuscular diseases, clinical research |
Project type | Network of Excellence |
Funding agency | European Commission |
Reference | FP6-036825 |
Objective | Improving trial-readiness worldwide, advancing patient diagnosis and care and accelerating pre-clinical research |
Project coordinator | Institute of Genetic Medicine, Newcastle University |
Participants | Universities, pharmaceutical companies, patient organisations |
Website |
www |
TREAT-NMD (treat NeuroMuscular Disease) is a global academic network that focuses on advancing research in neuromuscular disorders. [1] It was established in 2007 with its coordination centre at the Newcastle University. [2] As of 2018, the network comprises over a hundred research centres and patient organisations from 54 countries [3] as well as independent academics and patient representatives. [4] The network's aim is to provide infrastructure to accelerating research through supporting collaboration between its members. [5] Its main goals include improving trial-readiness worldwide, advancing patient diagnosis and care and accelerating pre-clinical research. [6] [7]
Through patient registries, TREAT-NMD provides genotype– phenotype correlation between genetic mutations and neuromuscular disease burden. [8]